|YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway|
Y Zhao, P Khanal, P Savage, YM She, TD Cyr, X Yang
Cancer research 74 (16), 4493-4503, 2014
|ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer|
G Deblois, HW Smith, IS Tam, SP Gravel, M Caron, P Savage, DP Labbé, ...
Nature communications 7 (1), 1-14, 2016
|The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression|
MA Goyette, S Duhamel, L Aubert, A Pelletier, P Savage, MP Thibault, ...
Cell reports 23 (5), 1476-1490, 2018
|Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis|
S Tabariès, MG Annis, BE Hsu, CE Tam, P Savage, M Park, PM Siegel
Oncotarget 6 (11), 9476, 2015
|Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation|
S Tahmasebi, M Ghorbani, P Savage, K Yan, G Gocevski, L Xiao, L You, ...
Journal of Biological Chemistry 288 (18), 12791-12804, 2013
|A targetable EGFR-dependent tumor-initiating program in breast cancer|
P Savage, A Blanchet-Cohen, T Revil, D Badescu, SMI Saleh, YC Wang, ...
Cell reports 21 (5), 1140-1149, 2017
|The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency|
S Tahmasebi, M Ghorbani, P Savage, G Gocevski, XJ Yang
Stem cells 32 (4), 1012-1020, 2014
|Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanomas|
M Dankner, M Lajoie, D Moldoveanu, TT Nguyen, P Savage, S Rajkumar, ...
Clinical Cancer Research 24 (24), 6483-6494, 2018
|Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program|
A Hirukawa, HW Smith, D Zuo, CR Dufour, P Savage, N Bertos, ...
Nature communications 9 (1), 1-15, 2018
|Canadian MD-Ph. D. Programs Produce Impactful Physician-Scientists: The McGill Experience|
TE Zhou, PA Savage, MJ Eisenberg
Neurology 2, 22.2, 2016
|Motif-based evidence that a plastid translocon component acts like a rhomboid protease substrate in yeast mitochondria|
J Powles, P Savage, E Wu, K Karakasis, K Ko
Botany 89 (7), 499-511, 2011
|DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy|
C Bernier, A Soliman, M Gravel, M Dankner, P Savage, K Petrecca, ...
Anti-cancer drugs 29 (8), 774, 2018
|Activation of the pattern recognition receptor NOD1 augments colon cancer metastasis|
HY Jiang, S Najmeh, G Martel, E MacFadden-Murphy, R Farias, P Savage, ...
Protein & cell 11 (3), 187-201, 2020
|The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication|
P Savage, N Yu, S Dumitra, S Meterissian
European Journal of Surgical Oncology 45 (10), 1817-1820, 2019
|Epigenetic switch–induced viral mimicry evasion in chemotherapy-resistant breast cancer|
G Deblois, SAM Tonekaboni, G Grillo, C Martinez, YI Kao, F Tai, I Ettayebi, ...
Cancer discovery 10 (9), 1312-1329, 2020
|An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis|
HW Smith, A Hirukawa, V Sanguin-Gendreau, I Nandi, CR Dufour, D Zuo, ...
Nature communications 10 (1), 1-19, 2019
|Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors|
P Savage, A Pacis, H Kuasne, L Liu, D Lai, A Wan, M Dankner, ...
Communications biology 3 (1), 1-15, 2020
|Incidence and predictors of postoperative ileus after loop ileostomy closure: a systematic review and meta-analysis|
R Garfinkle, P Savage, M Boutros, T Landry, P Reynier, N Morin, ...
Surgical endoscopy, 1-14, 2019
|65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES|
M Dankner, M Caron, T Al-Saadi, WQ Yu, V Ouellet, P Uyen Le, ...
Neuro-Oncology Advances 2 (Supplement_2), ii13-ii14, 2020
|TMOD-41. ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODELS OF BRAIN METASTASIS: PLATFORMS FOR PRECISION ONCOLOGY AND UNDERSTANDING TUMOR BIOLOGY|
M Dankner, P Savage, A Rose, M Lajoie, R Diaz, M Park, I Watson, ...
Neuro-oncology 21 (Supplement_6), 2019